Target intelligence / Profile preview

ATP-binding cassette transporter (ABC transporter) (ABC transporter)

Target
ABC transporter
Molecular classification
Transporter, ATP-binding cassette superfamily
01

Overview

ATP-binding cassette (ABC) transporters are a large superfamily of membrane proteins that utilize the energy of ATP hydrolysis to transport a wide variety of substrates across cellular membranes (NIH, 2022). In humans, there are 48-49 identified ABC transporters categorized into seven subfamilies (ABCA-ABCG), playing essential roles in nutrient uptake, lipid homeostasis, and the detoxification of xenobiotics (UniProt, 2023; StatPearls, 2023). These proteins are critical in pharmacology as they influence the absorption, distribution, and elimination of many drugs, and their overexpression is a primary cause of multidrug resistance (MDR) in cancer (PubMed, 2021). Mutations in ABC transporter genes are linked to numerous genetic disorders, including cystic fibrosis (CFTR/ABCC7), Stargardt disease (ABCA4), and Tangier disease (ABCA1) (NIH, 2002). Therapeutic strategies include the use of modulators to restore function in genetic defects or inhibitors to sensitize cancer cells to chemotherapy (Nature Reviews Drug Discovery, 2020). Additionally, they serve as important barriers in the blood-brain barrier and placenta, protecting sensitive tissues from toxic insults (ResearchGate, 2023).

Other names
ABC proteinTraffic ATPaseATP-binding cassette superfamilyABC transporters
02

Mechanism of action

ATP-dependent primary active transport of substrates across biological membranes against concentration gradients; some members function as ion channels or regulators of other channels (e.g., CFTR, SUR1) (NIH, 2022; StatPearls, 2023).

03

Biological functions

Active transportATP hydrolysisLipid homeostasisIon transportXenobiotic effluxAntigen presentationBile acid secretion
04

Disease associations

CancerCystic fibrosisStargardt diseaseTangier diseaseDubin-Johnson syndromeCholestasisAdrenoleukodystrophySitosterolemiaAlzheimer's diseaseDiabetes mellitus
05

Safety considerations

Drug-drug interactions (DDI) due to inhibition of efflux transportersPotential for drug-induced liver injury (DILI) via BSEP inhibitionAltered systemic exposure of co-administered substrate drugsChanges in blood-brain barrier permeability
06

Interacting drugs

Ivacaftor

13 more in the full profile.

07

Biomarkers

ABCB1 expression levelsCFTR genotype (e.g., F508del)ABCA4 mutationsBSEP (ABCB11) activityMRP1 expression

Beyond the preview

Go deeper on ATP-binding cassette transporter (ABC transporter) (ABC transporter).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette transporter (ABC transporter) (ABC transporter).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call